← All Sponsors
SPONSOR

Electra Therapeutics Inc.

Total Trials
1
Recruiting
1
Phases
Phase 2, Phase 3
Conditions studied: Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
NCT05416307 Phase 2, Phase 3
Recruiting

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
United States, Austria, Germany View Trial →